Clinical Trials Logo

Clinical Trial Summary

A Multicentre, Randomized, Double-blind, Parallel Design Phase III Study to Evaluate the efficacy and safety of QLG2071 Versus Cleviprex® in the Treatment of Hypertensive Emergency and Sub-emergency


Clinical Trial Description

This is a multicenter, randomized, double-blind, active-compared Phase III clinical study to evaluate the efficacy and safety of clevidipine butyrate injectable emulsion in the treatment of Hypertensive Emergency and Sub-emergency. The Cleviprex® will be chosen as the positive controlled medicine with the same usage of the test drug ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05922436
Study type Interventional
Source Qilu Pharmaceutical (Hainan) Co., Ltd.
Contact Yuguo Chen
Phone 0531-82169022
Email chen919085@126.com
Status Not yet recruiting
Phase Phase 3
Start date July 15, 2023
Completion date May 25, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05044364 - Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02924805 - Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies N/A
Active, not recruiting NCT05155202 - Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
Not yet recruiting NCT05783557 - A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT04553653 - Improving Acute Hypertension Management Through Emergency Department Checklist N/A
Recruiting NCT04670809 - Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Phase 3
Completed NCT02672787 - A ED-based Intervention to Improve Antihypertensive Adherence N/A
Not yet recruiting NCT06201572 - The Value of TOI in Evaluating Renal Function Damage in Hypertensive Emergency Patients
Not yet recruiting NCT05139238 - Postpartum Hypertension Study Phase 4
Not yet recruiting NCT06286696 - Optic Nerve Sheath Diameter in Hypertensive Emergency